EXEL Mary C Beckerle sells $1.0M worth of shares
Nov 14, 2025, 5:34 AM
0.00%
What does EXEL do
Exelixis, an oncology company based in Alameda, California, focuses on developing treatments for difficult-to-treat cancers, with four marketed products including cabozantinib for various cancers. Founded in 2000, it employs 1,310 people.
Mary C Beckerle sold 24,622 shares of EXEL on 11 November at $41.90 per share, worth a total of $1.0M. They now own 40,218 EXEL shares, or a 54% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.